A detailed history of Banque Transatlantique Sa transactions in Incyte Corp stock. As of the latest transaction made, Banque Transatlantique Sa holds 465 shares of INCY stock, worth $29,876. This represents 0.0% of its overall portfolio holdings.

Number of Shares
465
Holding current value
$29,876
% of portfolio
0.0%

Shares

1 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2025

May 15, 2025

BUY
$60.0 - $75.26 $27,900 - $34,995
465 New
465 $28,000

Others Institutions Holding INCY

About INCYTE CORP


  • Ticker INCY
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 222,431,008
  • Market Cap $14.3B
  • Description
  • Incyte Corporation, a biopharmaceutical company, focuses on the discovery, development, and commercialization of proprietary therapeutics in the United States and internationally. The company offers JAKAFI, a drug for the treatment of myelofibrosis and polycythemia vera; PEMAZYRE, a fibroblast growth factor receptor kinase inhibitor that act as ...
More about INCY
Track This Portfolio

Track Banque Transatlantique Sa Portfolio

Follow Banque Transatlantique Sa and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Banque Transatlantique Sa, based on Form 13F filings with the SEC.

News

Stay updated on Banque Transatlantique Sa with notifications on news.